Lessons Learnt from Glycogen Synthase Kinase 3 Inhibitors Development for Alzheimer's Disease

E-ISSN： 1873-4294|13|15|1808-1819

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.15, 2013-08, pp. : 1808-1819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease

By Medina Miguel Avila Jesús

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 69-77

Informa Healthcare

Access to resources Recommend Favorite

Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimer's Disease

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1389-1397

Bentham Science Publishers

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?

By Dorronsoro Isabel Castro Ana Martinez Ana

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1527-1536

Informa Healthcare

Access to resources Recommend Favorite